JPMorgan Announces Cash Distributions for the JPMorgan ETFs GlobeNewswire November 24, 2025 TORONTO, Nov. 24, 2025 (GLOBE NEWSWIRE) — J. P. Morgan Asset Management (JPMAM)* today announced the final November 2025 cash distributions for the below listed JPMorgan ETFs. The JPMorgan ETFs trade on the Toronto Stock Exchange (TSX). Unitholders of record on December 1, […]

Arvinas Announces Data Presentations from the Vepdegestrant (ARV-471) Clinical Development Program at the 2025 San Antonio Breast Cancer Symposium (SABCS) GlobeNewswire November 24, 2025 NEW HAVEN, Conn., Nov. 24, 2025 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that

Dianthus Therapeutics To Participate in the 8th Annual Evercore Healthcare Conference GlobeNewswire November 24, 2025 NEW YORK and WALTHAM, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) — Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today announced the Company's participation in the

Aquestive Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference GlobeNewswire November 24, 2025 WARREN, N.J., Nov. 24, 2025 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ:AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, announced today that the Aquestive

Boundless Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference GlobeNewswire November 24, 2025 SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) — Boundless Bio, (Nasdaq: BOLD) a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced that Zachary Hornby, President

Harrow to Present at Two Investor Conferences in December GlobeNewswire November 24, 2025 NASHVILLE, Tenn., Nov. 24, 2025 (GLOBE NEWSWIRE) — Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that management will participate in the following two investor conferences in December: BTIG 5th Annual Ophthalmology Day (Virtual)Format:

Edustaff Announces Partnership with Dover Public Schools, Expanding Service Footprint in New Jersey GlobeNewswire November 24, 2025 GRAND RAPIDS, Mich., Nov. 24, 2025 (GLOBE NEWSWIRE) — Edustaff, a leading K-12 educational staffing provider specializing in substitute teachers and support staff, is pleased to announce a new partnership with Dover Public Schools in New Jersey. This

GetYourGuide Unveils 2026 Hidden Trends List: Birdwatching, Coffee Culture and Skill-Seeking Set to Drive Experience-Led Trips The #1 app for for travel experiences reveals the key motivators inspiring travelers to book in 2026 GlobeNewswire November 24, 2025 BERLIN, Nov. 24, 2025 (GLOBE NEWSWIRE) — GetYourGuide, the leading global online marketplace for unforgettable travel experiences, today

Seres Therapeutics to Participate in Piper Sandler Healthcare Conference GlobeNewswire November 24, 2025 CAMBRIDGE, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) — Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that management will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on December 2, 2025, at 10:30 a.m.

Fortrea Completes $75.7 Million Senior Notes Tender Offer Utilizing Cash on Hand GlobeNewswire November 24, 2025 DURHAM, N.C., Nov. 24, 2025 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it has completed its debt tender offer (the “Tender Offer”) described in the Offer to Purchase